The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish Land Regulatory News (BLND)

Share Price Information for British Land (BLND)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 422.60
Bid: 420.60
Ask: 421.60
Change: 13.20 (3.22%)
Spread: 1.00 (0.238%)
Open: 412.00
High: 422.60
Low: 410.80
Prev. Close: 409.40
BLND Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

s430(2B) Companies Act disclosure

11 Jan 2021 09:00

RNS Number : 1491L
British Land Co PLC
11 January 2021
 

Website disclosure in accordance with s430(2B) of the Companies Act 2006

The following information is provided in accordance with section 430(2B) of the Companies Act.

On 10 September 2020 we announced that Chris Grigg would step down from his role as Chief Executive Officer of the British Land Company PLC (the Company) following delivery of the Company's 2021 interim results on 18 November 2020 and leave the Board and the Company on 31 December 2020.

As such, on 31 December 2020 Chris Grigg ceased to be a director of the Company and left the Company. The treatment of his remuneration on cessation has been determined by the Remuneration Committee in line with the terms of the Directors' remuneration policy (as approved by shareholders at the 2019 AGM), details of which are set out below. Full disclosure will also be included in the 2021 Annual Report and Accounts.

Following cessation of employment, he will receive monthly payments in lieu of notice for the remainder of his 12 months' notice period (to 9 September 2021). The total amount payable for the period following ceasing employment for the remainder of the notice period comprises base salary and car allowance of £615,787, pension contributions/allowance of £131,759 and the value of other benefits of £6,066. These payments may be reduced by the value of any alternative paid employment secured during the period until 9 September 2021.

Chris Grigg will also be eligible for an annual bonus for the 2020/21 financial year, subject to the satisfaction of a combination of corporate and personal objectives. The maximum bonus opportunity will be £983,178. Details of the performance achieved against the targets will be set out in the Directors' Remuneration Report. In line with the terms of the Directors' remuneration policy, two-thirds of any annual bonus will be paid in cash and one-third will be used to purchase British Land shares which shall be held on trust for a period of three years.

Chris Grigg will be treated as a "good leaver" under the Company's Long Term Incentive Plan. Consequently, awards will be reduced on a time pro-rata basis and will continue to vest on the normal vesting dates, subject to the extent to which the applicable performance criteria have been met:

1. A maximum of 263,276 Performance Shares may vest under the 2018 LTIP awards; and

2. A maximum of 196,145 Performance Shares may vest under the 2019 LTIP awards; and

3. A maximum of 83,604 Performance Shares may vest under the 2020 LTIP awards.

Vesting levels will be confirmed in the respective Directors' Remuneration Reports, with dividend equivalents being paid in respect of any shares vesting. In line with the Directors' Remuneration Policy, any shares delivered will be subject to a 2 year holding period.

Chris Grigg also holds vested but unexercised LTIP options which were granted in 2011 and 2012. He will have six months following departure to exercise these awards. Awards under the SAYE and SIP all employee plans will also lapse on cessation.

A contribution towards his legal fees of £10,000 plus VAT was provided.

Enquiries:

Analysts & Investors

Joanna Waddingham

 

07714 901166

Media

Charlotte Whitley

 

07887 802535

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKFBDFBKDCDK
Date   Source Headline
15th Jul 20202:00 pmRNSDirector/PDMR Shareholding
8th Jul 20201:43 pmRNSDirector/PDMR Shareholding
1st Jul 20207:00 amRNSJune Operational Update
30th Jun 20202:16 pmRNSDirector/PDMR Shareholding
30th Jun 20202:03 pmRNSAnnual Financial Report & Notice of AGM
30th Jun 202012:58 pmRNSTotal Voting Rights
23rd Jun 202010:00 amRNSDirector/PDMR Shareholding
16th Jun 20204:30 pmRNSDirector/PDMR Shareholding
10th Jun 20201:36 pmRNSHolding(s) in Company
9th Jun 20207:00 amRNSPublication of Supplementary Prospectus
29th May 20202:44 pmRNSTotal Voting Rights
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSFinal Results
21st May 20209:00 amRNSDirectorate Change
15th May 20201:24 pmRNSDirector/PDMR Shareholding
14th May 20203:27 pmRNSHolding(s) in Company
4th May 20204:06 pmRNSHolding(s) in Company
1st May 202012:34 pmRNSDisclosure of rights attached to equity shares
30th Apr 20202:58 pmRNSTotal Voting Rights
29th Apr 20207:09 amRNSRevised FY20 results and AGM dates
16th Apr 20209:00 amRNSBoard Remuneration and Community Investment Fund
15th Apr 20203:57 pmRNSDirector/PDMR Shareholding
6th Apr 20202:09 pmRNSDirector/PDMR Shareholding
3rd Apr 20202:20 pmRNSHolding(s) in Company
2nd Apr 20207:00 amRNSBlock listing Interim Review
26th Mar 202012:31 pmRNSHolding(s) in Company
26th Mar 20207:00 amRNSBusiness and dividend update
19th Mar 20207:00 amRNSDirectorate Change
17th Mar 20202:26 pmRNSDirector/PDMR Shareholding
13th Mar 20203:51 pmRNSHolding(s) in Company
3rd Mar 20202:07 pmRNSHolding(s) in Company
28th Feb 20204:05 pmRNSTotal Voting Rights
17th Feb 202012:11 pmRNSDirector/PDMR Shareholding
11th Feb 20203:38 pmRNSHolding(s) in Company
11th Feb 202010:58 amRNSDirector/PDMR Shareholding
31st Jan 202010:59 amRNSTotal Voting Rights
28th Jan 20205:38 pmRNSDividend Declaration
15th Jan 202012:23 pmRNSDirector/PDMR Shareholding
9th Jan 202010:46 amRNSHolding(s) in Company
3rd Jan 20202:16 pmRNSDirector/PDMR Shareholding
2nd Jan 20203:48 pmRNSTotal Voting Rights
2nd Jan 202012:00 pmRNSConvertible Bond Exchange Price Adjustment
18th Dec 201911:52 amRNSDirector/PDMR Shareholding
16th Dec 20193:00 pmRNSDirector/PDMR Shareholding
12th Dec 201911:30 amRNSDirector/PDMR Shareholding
29th Nov 201910:19 amRNSTotal Voting Rights
27th Nov 20194:30 pmRNSHolding(s) in Company
15th Nov 20192:05 pmRNSDirector/PDMR Shareholding
14th Nov 201912:03 pmRNSHolding(s) in Company
13th Nov 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.